Literature DB >> 7562558

Acute amiodarone terminates ventricular fibrillation by modifying cellular Ca++ homeostasis in isolated perfused rat hearts.

S Kojima1, S T Wu, J Wikman-Coffelt, W W Parmley.   

Abstract

Intravenous amiodarone has an acute antiarrhythmic action, which may be mediated by effects on intracellular calcium concentration [Ca++]i. We evaluated termination of pacing-induced ventricular fibrillation (VF) and associated changes in [Ca++]i by acute amiodarone in isolated perfused rat hearts loaded with the [Ca++]i indicator 1-(2-amino-5-(6-carboxy-2- indolyl)phenoxy)-2-(2-amino-5-methylphenoxy)ethane-N,N,N',N'-tetraacetic acid pentaacetoxymethyl ester. [Ca++]i was evaluated with surface fluorometry through fiberoptics placed on the interventricular septum. Two minutes after VF induction, hearts were perfused with amiodarone (n = 12, 10 micrograms/ml for 5 min followed by 1 micrograms/ml), low extracellular calcium concentration [Ca++]o (n = 12, 0.2 mM) or a control perfusate (n = 12, no treatment). VF termination during a 30-min observation period was significantly more frequent with amiodarone (92%) and with low [Ca++]o (75%) compared with no treatment (17%, P < .05). In nontreated hearts without recovery, [Ca++]i, expressed as a percentage of the base-line amplitude, increased continuously from 206% +/- 44% to 529% +/- 138% during 30-min VF (P < .05). In hearts that recovered with amiodarone and low [Ca++]o, [Ca++]i decreased significantly from 273% +/- 55% and 273% +/- 99% before treatment to 122% +/- 95% and 50% +/- 80% before defibrillation, respectively (P < .05). VF frequency was also significantly decreased with amiodarone. The nature of [Ca++]i transients in VF has not been fully known. Power spectrum analysis disclosed that [Ca++]i transients responded to every one or two electrocardiographic signals in VF with the highest frequency of 22 Hz.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7562558

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  Effects of metoprolol and amiodarone combination on heart rate, myocardial contractility and coronary flow: Study in isolated perfused rat hearts.

Authors:  Wagner C Pádua-Filho; David P Brasil; Hueverson J Neves; Otoni M Gomes; Edimar A Bocchi
Journal:  Exp Clin Cardiol       Date:  2004

Review 2.  Effect of drugs on defibrillation capacity.

Authors:  Anna Legreid Dopp; John M Miller; James E Tisdale
Journal:  Drugs       Date:  2008       Impact factor: 9.546

3.  Current concepts on ventricular fibrillation: a vicious circle of cardiomyocyte calcium overload in the initiation, maintenance, and termination of ventricular fibrillation.

Authors:  Christian E Zaugg
Journal:  Indian Pacing Electrophysiol J       Date:  2004-04-01

4.  Assessing the translatability of in vivo cardiotoxicity mechanisms to in vitro models using causal reasoning.

Authors:  Ahmed E Enayetallah; Dinesh Puppala; Daniel Ziemek; James E Fischer; Sheila Kantesaria; Mathew T Pletcher
Journal:  BMC Pharmacol Toxicol       Date:  2013-09-06       Impact factor: 2.483

5.  Effect of flunarizine on defibrillation outcomes and early refibrillation in a canine model of prolonged ventricular fibrillation.

Authors:  Chaofan Xing; Qi Jin; Ning Zhang; Shaohua Liu; Changjian Lin; Qiong Wu; Qingzhi Luo; Ao Liu; Liqun Wu
Journal:  Exp Physiol       Date:  2019-10-09       Impact factor: 2.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.